Pandora A/S has been notified of transactions in the Pandora A/S share by a person discharging managerial responsibilities and/or closely associated persons. Lilian Fossum Biner, Board member of ...

Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

How do you turn around the world's largest fashion jewellery brand while keeping ESG goals in mind? BAZAAR Australia asked ...

Cadeler announces the signing of a Vessel Reservation Agreement (VRA) with Ocean Winds for the installation of the wind ...

The Annual General Meeting (the "Meeting”) of Pandora A/S (the "Company") is hereby convened to be held on Wednesday, 12 March 2025 at 10:00 a.m. CET (doors will open at 9:30) The Meeting will be held ...

Operating profit increased by 25% in Danish kroner and by 26% at constant exchange rates (CER) to DKK 128.3 billion.

Novo Nordisk has projected slower growth after Wegovy sales more than doubled, amid competition from Eli Lilly. Though shares rose following improved earnings, concerns linger about U.S. demand.

By Maggie Fick and Stine Jacobsen LONDON/COPENHAGEN (Reuters) -Obesity drug maker Novo Nordisk forecast slower growth this ...

In an update to the Copenhagen Stock Exchange, the club said: "Aalborg Boldspilklub A/S is experiencing great interest in several players and has now received a concrete offer from a foreign club ...

The shares of BioPorto A/S are listed on the Nasdaq Copenhagen stock exchange. For more information visit www.bioporto.com. Forward-looking statement disclaimer Certain statements in this news ...

The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...